Treatment(s) now being considered-Surgery Posts on Medivizor

Evaluating the effectiveness and safety of mFOLFOXIRI chemotherapy with or without radiotherapy before surgery in patients with locally advanced rectal cancer

Posted by Medivizor on Jan 26, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safery of administering modified (m) FOLFOXIRI (folinic acid, fluorouracil, irinotecan, oxaliplatin) chemotherapy with or without radiotherapy before surgery in patients with locally advanced rectal cancer (LARC). The results showed that this treatment was safe and improved survival without disease...

Evaluating outcomes of laparoscopic surgery for the treatment of elderly patients over 80 years with colorectal cancer.

Posted by Medivizor on Jul 31, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the short- and long-term outcomes of laparoscopic surgery (LS; keyhole surgery) for the treatment of elderly patients with colorectal cancer (CRC) aged over 80 years. The data showed that LS is a good and safe option for these patients. Some background Colorectal cancer (CRC) is one of the most common types of cancer...

Evaluating the effectiveness and safety of total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Posted by Medivizor on Jul 17, 2021 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy (CRT) for the treatment of patients with locally advanced rectal cancer (LARC). The data showed that TNT was associated with improved outcomes compared with standard CRT for these patients. Some background...

Does adding chemotherapy after surgery for liver metastasis improve the long-term outcome of patients with colorectal cancer?

Posted by Medivizor on Jun 6, 2021 in Colorectal cancer | 0 comments

In a nutshell The study investigated the impact of adding chemotherapy after surgery to remove liver metastasis on the outcomes of patients with colorectal cancer (CRC). The study reported a significantly longer survival in patients undergoing further chemotherapy. Some background Up to 50% of patients with CRC develop...

Can addition if oxaplatin to tegafur–uracil/leucovorin improve the outcome of patients with colorectal cancer?

Posted by Medivizor on Apr 30, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate the impact of adding oxaliplatin (Eloxatin) to the chemotherapy regimen tegafur uracil (UFT)/leucovorin (LV; folinic acid) for patients that had surgery for colorectal cancer (CRC). The study found that the addition of oxaliplatin to UFT/LV improved patient outcomes. Some background CRC can...

Comparing laparoscopic versus open surgery for patients with rectal cancer.

Posted by Medivizor on Apr 25, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to compare the outcome of laparoscopic (keyhole surgery) and open surgery for patients with rectal cancer. The study found no difference in patient outcomes between laparoscopic and open surgery groups. Some background Localized rectal cancer can be treated by surgical removal of the tumor. Usually, patients...

How do different types of rectal cancer surgery impact urinary and sexual function?

Posted by Medivizor on Apr 11, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate the urinary and sexual function of patients following 2 types of rectal cancer surgery. The study found that in men, robotic surgery resulted in better urinary and sexual function. Some background Rectal cancer can be treated by surgical removal of the tumor. Therapy for rectal cancer has improved...

High-dose rate intraoperative brachytherapy is associated with improved outcomes in patients with high-risk rectal cancer

Posted by Medivizor on Apr 3, 2021 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of electron beam radiotherapy (EBR) and high-dose brachytherapy (HDB) during surgery in patients with rectal cancer who underwent an incomplete removal of the cancer. Researchers suggested that HDB was associated with a lower risk of recurrence in these patients. Some background Colorectal...

Evaluating surgery and chemotherapy versus chemotherapy alone for the treatment of metastatic colorectal cancer.

Posted by Medivizor on Mar 31, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated whether surgery of colorectal cancer (CRC) followed by chemotherapy (CT) improved the outcomes of patients with metastatic (spread) CRC compared to CT alone. The study found that there was no difference in patients' outcomes whether surgery was given or not. Some background CRC is the third most common cancer...

Can SOX and mFOLFOX6 chemotherapies be given without radiotherapy before surgery for advanced rectal cancer?

Posted by Medivizor on Jan 31, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the safety and effectiveness of two chemotherapy regimens (SOX and mFOLFOX6) before surgery for rectal cancer (RC) without radiotherapy. The study found that both regimens were safe and effective in these patients. Some background RC is commonly treated with surgery to remove the tumor. Patients with...

Liver partition and portal vein ligation improves long-term outcomes of patients with colorectal cancer and liver metastases

Posted by Medivizor on Dec 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the long-term outcomes of patients with colorectal cancer (CRC) and liver metastases (LM; cancer spread to the liver) undergoing the ALPPS (associating liver partition and portal vein ligation) procedure. Researchers suggested that patients with LM that were unfit for surgical removal achieved positive long-term...

What is the optimal timing of surgery for liver metastasis after chemotherapy in patients with colorectal cancer?

Posted by Medivizor on Dec 30, 2020 in Colorectal cancer | 0 comments

In a nutshell The study evaluated the optimal timing of surgery for colorectal cancer liver metastasis (CRLM) after chemotherapy (CT). The main finding was that surgery within 5 weeks after CT may improve patients' outcomes. Some background Chemotherapy (CT) is used before surgery to remove tumors to reduce tumor size. This is...

Treatment(s) now being considered-Surgery Posts on Medivizor

Evaluating the effectiveness and safety of mFOLFOXIRI chemotherapy with or without radiotherapy before surgery in patients with locally advanced rectal cancer

Evaluating outcomes of laparoscopic surgery for the treatment of elderly patients over 80 years with colorectal cancer.

Evaluating the effectiveness and safety of total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Does adding chemotherapy after surgery for liver metastasis improve the long-term outcome of patients with colorectal cancer?

Can addition if oxaplatin to tegafur–uracil/leucovorin improve the outcome of patients with colorectal cancer?

Comparing laparoscopic versus open surgery for patients with rectal cancer.

How do different types of rectal cancer surgery impact urinary and sexual function?

High-dose rate intraoperative brachytherapy is associated with improved outcomes in patients with high-risk rectal cancer

Evaluating surgery and chemotherapy versus chemotherapy alone for the treatment of metastatic colorectal cancer.

Can SOX and mFOLFOX6 chemotherapies be given without radiotherapy before surgery for advanced rectal cancer?

Liver partition and portal vein ligation improves long-term outcomes of patients with colorectal cancer and liver metastases

What is the optimal timing of surgery for liver metastasis after chemotherapy in patients with colorectal cancer?

Categories

Recent Posts

Archives

Treatment(s) now being considered-Surgery Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email